Find a company
| Project | Direct from Blood Rapid Antimicrobial Susceptibility Test |
|---|---|
| Description |
A method to quickly and automatically separate viable bacteria from the other constituents of positive blood cultures, enabling them to be processed in iFAST's revolutionary Antimicrobial Susceptibility Testing system. We use patented impedance flow cytometry to determine the most appropriate antibiotics to treat bacterial infections, giving results in 2-3 hours compared with 2-3 days with current clinical methods. This will save thousands of lives, improve outcomes and help antimicrobial stewardship. |
| Funding | £ 99,817 |
| Competition | Competition 25 - AMR |
| Competition Date | July 2024 |
| Categories | Antimicrobial Resistance (AMR) |
| Health Innovation Network Partner | Health Innovation Wessex |
| Website | https://ifastdiagnostics.com/ |